Title: Financial News– LegoChem Bioscience in Daejeon Techno Park, KOSDAQ IPO approved.
Publication: Financial News
Date: 02 January 2013
Summary
Daejeon City
announced that one of city-sponsored venture companies, LegoChem Biosciences,
Inc. got approved by KOSDAQ of preliminary evaluation for IPO. With Korea
Investment Co., Ltd. as an assistant administrator, LegoChem will go through
official procedures for KOSDAQ IPO including the subscription scheduled in
March.
To view the full article
(in Korean), click here ▶
About
LegoChem Biosciences
LegoChem
Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to
discovering, developing, and commercializing innovative medicines by leveraging
our chemistry expertise to make conventional biologics targeted and more potent
for the benefit of patients with diseases of high unmet medical needs. We are
advancing sustainable pipelines in therapeutic areas in antibiotics,
anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug
conjugate (PDC).
|
|
IP : 106.243.208.*** 
|
